Classifieds |
Web |
My |
Home |
Pictures |
Wiki |
Lyrics |
Games |
Jokes |
Recipes |
Radio |
Today |
HELP
Bollywood | Juicy Gossip | Current Affairs | News | Hollywood | Galatta | Broadband | Trailers | HiDef
Bollywood | Juicy Gossip | Current Affairs | News | Hollywood | Galatta | Broadband | Trailers | HiDef
Recently Featured | Most Discussed | Most Recent | Most Responded | Most Viewed | Top Favorites | Top Rated | TV Serials | Trailers | Recently Watched
Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade
This ad will close in 15 seconds
Rate:
3 ratings
Views:
2,169
From : DefendingTheConsumer
Added: Dec 6, 2008
The manufacturers of Humira (adalimumab), Cimzia (certolizumab pegol), Enbrel (etanercept), and Remicade (infliximab) must strengthen warnings about the risk of developing opportunistic fungal infections from these drugs. These infections have been fatal in some patients. Humira, Cimzia, Enbrel, and Remicade are tumor necrosis factor alpha blockers (TNF blocker) which suppress the immune system. These drugs are approved to treat one or more of several diseases, including juvenile idiopathic arthritis, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ankylosing spondylitis.
Category : News
Added: Dec 6, 2008
The manufacturers of Humira (adalimumab), Cimzia (certolizumab pegol), Enbrel (etanercept), and Remicade (infliximab) must strengthen warnings about the risk of developing opportunistic fungal infections from these drugs. These infections have been fatal in some patients. Humira, Cimzia, Enbrel, and Remicade are tumor necrosis factor alpha blockers (TNF blocker) which suppress the immune system. These drugs are approved to treat one or more of several diseases, including juvenile idiopathic arthritis, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ankylosing spondylitis.
Category : News
Related Videos
FDA is reminding healthcare professionals about the risk of serious fungal infections with TNF blockers, including Simponi (golimumab), which was recently approved. TNF blockers ...
The manufacturers of Humira (adalimumab), Cimzia (certolizumab pegol), Enbrel (etanercept), and Remicade (infliximab) must strengthen warnings about the risk of developing ...
FDA is reminding healthcare professionals about the risk of serious fungal infections with TNF blockers, including Simponi (golimumab), which was recently approved. TNF blockers ...
Video Categories:
Also Try:
